Ultrasound Elastography in Imaging Patients With Thyroid Nodules
- Conditions
- Thyroid Gland NoduleMalignant Thyroid Gland Neoplasm
- Interventions
- Device: Siemens Acuson S3000 ultrasound system
- Registration Number
- NCT03174925
- Lead Sponsor
- Stanford University
- Brief Summary
This clinical trial studies how well ultrasound elastography works in assessing the cancer status of potentially malignant thyroid nodules.
- Detailed Description
PRIMARY OBJECTIVES:
Determine the utility of ultrasound elastography in evaluation of thyroid nodules being evaluated for the presence of cancer.
Elastography measures the passages of ultrasound shear waves through tissue to gauge the stiffness and compressibility of the tissue, collectively "tissue stiffness," and may be a better way to image thyroid nodules. Tissue stiffness is a physiological parameter that is being evaluated for differences between non-cancerous (benign) and cancerous thyroid nodules.
Participants will undergo elastography over the 10 minutes prior to either fine needle aspiration of a biopsy specimen or surgical resection of the thyroid nodule. Tissue specimens from the biopsy specimen or surgical resection will be assessed pathologically to determine actual cancer status.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 55
- Presence of a thyroid nodule that is amenable to ultrasound guided fine needle aspiration
- Patients who are unable to lie supine for a biopsy
- Pregnant patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Tissue Stiffness by Elastography Siemens Acuson S3000 ultrasound system Potentially cancerous thyroid nodules were assessed by elastrography, then a fine needle biopsy specimen or the surgically-excised nodule was assessed pathologically to determine cancer status.
- Primary Outcome Measures
Name Time Method Stiffness of Thyroid Nodules as Measured by Elastography 1 week Potentially cancerous thyroid nodules will be assessed elastographically, and cancer status will be determined from a fine needle aspiration biopsy results or the surgically excised nodule. The outcome will be reported as median tissue stiffness with standard deviation for nodules that were determined non-cancerous (benign), cancerous, or indeterminate.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University, School of Medicine
🇺🇸Palo Alto, California, United States